Capital International Investors Buys New Position in Semler Scientific, Inc. (NASDAQ:SMLR)

Capital International Investors purchased a new position in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 570,610 shares of the company's stock, valued at approximately $30,813,000. Capital International Investors owned about 6.16% of Semler Scientific as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in SMLR. State Street Corp boosted its holdings in Semler Scientific by 0.6% during the third quarter. State Street Corp now owns 118,223 shares of the company's stock worth $2,784,000 after buying an additional 725 shares during the last quarter. Jane Street Group LLC raised its position in shares of Semler Scientific by 72.3% in the 3rd quarter. Jane Street Group LLC now owns 16,982 shares of the company's stock valued at $400,000 after acquiring an additional 7,126 shares during the period. Geode Capital Management LLC boosted its stake in Semler Scientific by 10.5% during the 3rd quarter. Geode Capital Management LLC now owns 135,959 shares of the company's stock worth $3,202,000 after acquiring an additional 12,964 shares during the last quarter. Sanctuary Advisors LLC bought a new position in Semler Scientific during the 3rd quarter worth approximately $104,000. Finally, Principal Financial Group Inc. acquired a new position in Semler Scientific during the third quarter valued at approximately $361,000. 49.37% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital increased their target price on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a report on Friday, January 24th.

Semler Scientific Stock Performance

NASDAQ:SMLR traded up $0.16 on Thursday, reaching $34.44. The company's stock had a trading volume of 142,805 shares, compared to its average volume of 402,823. Semler Scientific, Inc. has a 1-year low of $20.88 and a 1-year high of $81.56. The business's 50-day moving average price is $37.39 and its two-hundred day moving average price is $45.88. The firm has a market cap of $330.52 million, a PE ratio of 7.01 and a beta of 1.29.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $3.21. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The business had revenue of $12.41 million during the quarter.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.